Tokman Alexander Y
- SEC CIK
- 0001334483
No open-market purchases or sales filed in the past year.
Current role at each company
- NDRA ENDRA Life Sciences Inc.Chief Executive Officeras of Mar 4, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Tokman Alexander Y as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 28, 2022 (view filing)5:00 PM ET | Nov 23 | 5 days | Tokman Alexander YDirector | PPurchase | +10.0K | $0.17 | +$1.70K | +6.5%162.9K after | |
| Aug 24, 2022 (view filing)8:55 AM ET | Aug 22 | 2 days | Tokman Alexander YDirector | PPurchase | +20.0K | $0.26 | +$5.20K | +15.1%152.9K after | |
| May 17, 2022 (view filing)4:14 PM ET | May 16 | 1 day | Tokman Alexander YDirector | PPurchase | +100.0K | $0.1963 | +$19.6K | +304.3%132.9K after |